# The Safety and Efficacy of SPD465 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

> **NCT00928148** · PHASE2 · COMPLETED · sponsor: **Shire** · enrollment: 86 (actual)

## Conditions studied

- Attention-Deficit/Hyperactivity Disorder

## Interventions

- **DRUG:** SPD465
- **DRUG:** Immediate Release Amphetamine Salt
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00928148
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06-14
- **Primary completion:** 2004-11-20
- **Final completion:** 2004-11-20
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2021-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00928148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00928148, "The Safety and Efficacy of SPD465 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00928148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*